Synthetic Biology Patent Application Trends 2024
Revision as of 16:01, 11 December 2024 by Wikipatents (talk | contribs) (Updating Synthetic Biology Patent Application Trends 2024)
Contents
- 1 Synthetic Biology Patent Application Filing Activity
- 2 Synthetic Biology patent applications in 2024
- 3 Top Technology Areas in Synthetic Biology
- 4 Top Companies in Synthetic Biology
- 4.1 INBIOSE N.V.
- 4.2 The General Hospital Corporation
- 4.3 Fate Therapeutics, Inc.
- 4.4 PRIME MEDICINE, INC.
- 4.5 The Broad Institute, Inc.
- 4.6 Massachusetts Institute of Technology
- 4.7 The Board of Trustees of the Leland Stanford Junior University
- 4.8 UNIVERSITY OF MASSACHUSETTS
- 4.9 Wisconsin Alumni Research Foundation
- 4.10 Prime Medicine, Inc.
- 5 New Companies in Synthetic Biology (Last Month)
- 6 Emerging Technology Areas in Synthetic Biology
- 7 Top Companies in Emerging Synthetic Biology Technologies
- 8 Top Inventors in Synthetic Biology
- 8.1 Joeri Beauprez
- 8.2 Bahram VALAMEHR of San Diego CA (US)
- 8.3 David R. Liu of Cambridge MA (US)
- 8.4 Pieter Coussement
- 8.5 Thomas Decoene
- 8.6 Annelies Vercauteren
- 8.7 Ryan BJORDAHL of San Diego CA (US)
- 8.8 Jode GOODRIDGE of San Diego CA (US)
- 8.9 Kristof Vandewalle
- 8.10 Tom Tong LEE of San Diego CA (US)
- 8.11 Wei Hsi YEH of Cambridge MA (US)
- 8.12 Aaron Nakwon CHANG of Lexington MA (US)
- 8.13 Andrew Vito Anzalone of Cambridge MA (US)
- 8.14 Roman Lvovitch BOGORAD of South Boston MA (US)
- 8.15 Dewi HARJANTO of Brookline MA (US)
- 8.16 Sofie Aesaert
- 8.17 Gert Peters
- 8.18 Jin-Soo Kim
- 8.19 Seung Woo Cho
- 8.20 Sojung Kim
- 8.21 Krishanu Saha of Madison WI (US)
- 8.22 Lauren Sarko of Middleton WI (US)
- 8.23 Ante Sven Lundberg of Cambridge MA (US)
- 8.24 Chase Lawrence Beisel of Raleigh NC (US)
- 8.25 Scott Patrick Collins of Raleigh NC (US)
- 8.26 David Baram
- 8.27 Lior Izhar
- 8.28 Rafi Emmanuel
- 8.29 Jonathan M. LEVY of Brookline MA (US)
- 8.30 Yuan WANG
- 8.31 James William Nelson of Cambridge MA (US)
- 8.32 Chad Albert COWAN of South Boston MA (US)
- 8.33 Ante Sven LUNDBERG of South Boston MA (US)
- 8.34 Rasmus O. Bak of Stanford CA (US)
- 8.35 Ayal Hendel of Stanford CA (US)
- 8.36 Matthew H. Porteus of Stanford CA (US)
- 8.37 Michael Andreas Kock
- 8.38 Michael Lee Nuccio of Salem NH (US)
- 8.39 Frédéric Van Ex
- 8.40 Alexandra Elata of Arlington MA (US)
- 8.41 Daniel Rodriguez Leal of Raleigh NC (US)
- 8.42 Joshua L. Price of Cambridge MA (US)
- 8.43 Sofie De Maeseneire
- 8.44 Yatti De Nijs
- 8.45 Tom Delmulle
- 8.46 Yakeel T. Quiroz of Charlestown MA (US)
- 8.47 Joseph F. Arboleda-Velasquez of Newton MA (US)
- 8.48 Eric Reiman of Phoenix AZ (US)
- 8.49 Francisco Lopera
- 8.50 Radwanul Hasan SIDDIQUE of Monrovia CA (US)
- 9 Top Collaborations in Synthetic Biology
- 10 Top US States for Synthetic Biology Inventors
- 11 Top Cities for Synthetic Biology Inventors
Synthetic Biology Patent Application Filing Activity
Synthetic Biology patent applications in 2024
Top Technology Areas in Synthetic Biology
Top CPC Codes
- C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,)
- C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N15/102 ({Mutagenizing nucleic acids})
- C12N2800/80 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N15/111 ({General methods applicable to biologically active non-coding nucleic acids})
- Count: 26 patents
- Example: 20240229024. COMPOSITIONS FOR GENOME EDITING simplified abstract (EmendoBio Inc.)
- C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants)
- C12N15/86 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media)
- C12N15/63 (Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression)
Top Companies in Synthetic Biology
INBIOSE N.V.
- Number of Synthetic Biology patents: 9
- Top CPC codes:
- C12N9/1081 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
- C12P19/12 (FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer): 5 patents
- C12N9/1051 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 5 patents
- Recent patents:
The General Hospital Corporation
- Number of Synthetic Biology patents: 7
- Top CPC codes:
- C07K16/18 (PEPTIDES (peptides in foodstuffs): 2 patents
- A61P25/28 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 2 patents
- C07K14/775 (PEPTIDES (peptides in foodstuffs): 2 patents
- Recent patents:
- 20240240207. Increasing Specificity for RNA-Guided Genome Editing simplified abstract (The General Hospital Corporation) (20240718)
- 20240066102. Genome editing approaches to treat Spinal Muscular Atrophy simplified abstract (The General Hospital Corporation) (20240229)
- 20240218334. Biosensors in Human Gut Organoids simplified abstract (The General Hospital Corporation) (20240704)
Fate Therapeutics, Inc.
- Number of Synthetic Biology patents: 6
- Top CPC codes:
- A61K39/4631 ({Cellular immunotherapy}): 5 patents
- A61K39/4611 ({Cellular immunotherapy}): 4 patents
- A61P35/00 (Antineoplastic agents): 4 patents
- Recent patents:
- 20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES simplified abstract (Fate Therapeutics, Inc.) (20240919)
- 20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240425)
- 20240033355. ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS simplified abstract (Fate Therapeutics, Inc.) (20240201)
PRIME MEDICINE, INC.
- Number of Synthetic Biology patents: 4
- Top CPC codes:
- C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 patents
- C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 2 patents
- Recent patents:
- 20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240711)
- 20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS simplified abstract (PRIME MEDICINE, INC.) (20240912)
- 20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240523)
The Broad Institute, Inc.
- Number of Synthetic Biology patents: 4
- Top CPC codes:
- C12N15/111 ({General methods applicable to biologically active non-coding nucleic acids}): 4 patents
- C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
- C12N9/1276 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
- Recent patents:
- 20240117382. DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs) simplified abstract (The Broad Institute, Inc.) (20240411)
- 20240158779. METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE simplified abstract (The Broad Institute, Inc.) (20240516)
- 20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES simplified abstract (The Broad Institute, Inc.) (20241003)
Massachusetts Institute of Technology
- Number of Synthetic Biology patents: 4
- Top CPC codes:
- C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
- C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- C12N15/11 (DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology,): 2 patents
- Recent patents:
- 20240301373. FANZORS ARE RNA-GUIDED NUCLEASES ENCODED IN EUKARYOTIC GENOMES simplified abstract (Massachusetts Institute of Technology) (20240912)
- 20240067957. AUTOCATALYTIC BASE EDITING FOR RNA-RESPONSIVE TRANSLATIONAL CONTROL simplified abstract (Massachusetts Institute of Technology) (20240229)
- 20240035008. GENOMIC EDITING WITH SITE-SPECIFIC RETROTRANSPOSONS simplified abstract (Massachusetts Institute of Technology) (20240201)
The Board of Trustees of the Leland Stanford Junior University
- Number of Synthetic Biology patents: 4
- Top CPC codes:
- C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 4 patents
- C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
- C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- Recent patents:
- 20240263173. HIGH-THROUGHPUT PRECISION GENOME EDITING IN HUMAN CELLS simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20240808)
- 20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20241205)
- 20240018493. KNOCK-IN OF LARGE DNA FOR LONG-TERM HIGH GENOMIC EXPRESSION simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20240118)
UNIVERSITY OF MASSACHUSETTS
- Number of Synthetic Biology patents: 4
- Top CPC codes:
- C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
- C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
- C12N15/907 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- Recent patents:
- 20240141359. GENOME EDITING FOR TREATING MUSCULAR DYSTROPHY simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240502)
- 20240167029. MODIFIED GUIDE RNAS FOR CRISPR GENOME EDITING simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240523)
- 20240036027. Nanopore Biosensors and Uses Thereof simplified abstract (UNIVERSITY OF MASSACHUSETTS) (20240201)
Wisconsin Alumni Research Foundation
- Number of Synthetic Biology patents: 3
- Top CPC codes:
- A61K35/17 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms): 2 patents
- A61K39/4611 ({Cellular immunotherapy}): 2 patents
- A61K39/4631 ({Cellular immunotherapy}): 2 patents
- Recent patents:
- 20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation) (20240711)
- 20240131066. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation) (20240425)
- 20240026466. CELL-BASED DNA SENSORS AND METHODS OF USING SAME simplified abstract (Wisconsin Alumni Research Foundation) (20240125)
Prime Medicine, Inc.
- Number of Synthetic Biology patents: 3
- Top CPC codes:
- C12N9/22 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 3 patents
- C12N9/1276 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- C12N2310/20 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 2 patents
- Recent patents:
- 20240352453. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF RETINOPATHY simplified abstract (Prime Medicine, Inc.) (20241024)
- 20240376466. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF FANCONI ANEMIA simplified abstract (Prime Medicine, Inc.) (20241114)
- 20240360476. Genome Editing Compositions and Methods for Treatment of Myotonic Dystrophy simplified abstract (Prime Medicine, Inc.) (20241031)
New Companies in Synthetic Biology (Last Month)
No new companies detected in the last month.
Emerging Technology Areas in Synthetic Biology
- G01N27/44704 (using electrophoresis)
- Count: 1 patents
- Example: 20240044837. BIOSENSOR simplified abstract (Taiwan Semiconductor Manufacturing Company, Ltd.)
- B03C5/005 ({Dielectrophoresis, i.e. dielectric particles migrating towards the region of highest field strength ()
- Count: 1 patents
- Example: 20240044837. BIOSENSOR simplified abstract (Taiwan Semiconductor Manufacturing Company, Ltd.)
- G01N27/44782 (using electrophoresis)
- Count: 1 patents
- Example: 20240044837. BIOSENSOR simplified abstract (Taiwan Semiconductor Manufacturing Company, Ltd.)
- A61P25/00 (Drugs for disorders of the nervous system)
- G16B50/30 (BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY)
- G06N3/002 ({Biomolecular computers, i.e. using biomolecules, proteins, cells (using DNA)
- G01N33/02 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms)
- G01N27/227 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms)
- G01N27/221 (INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing processes other than immunoassay, involving enzymes or microorganisms)
- C12Y303/01001 (ENZYMES)
Top Companies in Emerging Synthetic Biology Technologies
- The Regents of the University of California: 3 patents
- Taiwan Semiconductor Manufacturing Company, Ltd.: 3 patents
- Regents of the University of Minnesota: 2 patents
- Beijing University of Chemical Technology: 1 patents
- The Trustees of Columbia University in the City of New York: 1 patents
Top Inventors in Synthetic Biology
Joeri Beauprez
- Number of Synthetic Biology patents: 9
- Top companies:
- INBIOSE N.V.: 9 patents
- Recent patents:
Bahram VALAMEHR of San Diego CA (US)
- Number of Synthetic Biology patents: 6
- Top companies:
- Fate Therapeutics, Inc.: 6 patents
- Recent patents:
- 20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES simplified abstract (Fate Therapeutics, Inc.) (20240919)
- 20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240425)
- 20240033355. ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS simplified abstract (Fate Therapeutics, Inc.) (20240201)
David R. Liu of Cambridge MA (US)
- Number of Synthetic Biology patents: 5
- Top companies:
- The Broad Institute, Inc.: 3 patents
- President and Fellows of Harvard College: 2 patents
- Recent patents:
- 20240271116. SUPPRESSION OF PAIN BY GENE EDITING simplified abstract (President and Fellows of Harvard College) (20240815)
- 20240209329. PROGRAMMABLE CAS9-RECOMBINASE FUSION PROTEINS AND USES THEREOF simplified abstract (President and Fellows of Harvard College) (20240627)
- 20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES simplified abstract (The Broad Institute, Inc.) (20241003)
Pieter Coussement
- Number of Synthetic Biology patents: 5
- Top companies:
- INBIOSE N.V.: 5 patents
- Recent patents:
- 20240368651. CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.) (20241107)
- 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
- 20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.) (20240613)
Thomas Decoene
- Number of Synthetic Biology patents: 5
- Top companies:
- INBIOSE N.V.: 5 patents
- Recent patents:
- 20240368651. CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.) (20241107)
- 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
- 20240191270. FERMENTATIVE PRODUCTION simplified abstract (INBIOSE N.V.) (20240613)
Annelies Vercauteren
- Number of Synthetic Biology patents: 5
- Top companies:
- INBIOSE N.V.: 5 patents
- Recent patents:
- 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
- 20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES simplified abstract (INBIOSE N.V.) (20240201)
- 20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES simplified abstract (INBIOSE N.V.) (20241003)
Ryan BJORDAHL of San Diego CA (US)
- Number of Synthetic Biology patents: 4
- Top companies:
- Fate Therapeutics, Inc.: 4 patents
- Recent patents:
- 20240115602. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240411)
- 20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES simplified abstract (Fate Therapeutics, Inc.) (20240919)
- 20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240425)
Jode GOODRIDGE of San Diego CA (US)
- Number of Synthetic Biology patents: 4
- Top companies:
- Fate Therapeutics, Inc.: 4 patents
- Recent patents:
- 20240115602. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240411)
- 20240307540. PROTECTED EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES simplified abstract (Fate Therapeutics, Inc.) (20240919)
- 20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240425)
Kristof Vandewalle
- Number of Synthetic Biology patents: 4
- Top companies:
- INBIOSE N.V.: 4 patents
- Recent patents:
- 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
- 20240035004. VARIANT SUCROSE PERMEASE POLYPEPTIDES simplified abstract (INBIOSE N.V.) (20240201)
- 20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES simplified abstract (INBIOSE N.V.) (20241003)
Tom Tong LEE of San Diego CA (US)
- Number of Synthetic Biology patents: 3
- Top companies:
- Fate Therapeutics, Inc.: 3 patents
- Recent patents:
- 20240226293. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240711)
- 20240115602. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240411)
- 20240131156. ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF simplified abstract (Fate Therapeutics, Inc.) (20240425)
Wei Hsi YEH of Cambridge MA (US)
- Number of Synthetic Biology patents: 3
- Top companies:
- PRIME MEDICINE, INC.: 2 patents
- Prime Medicine, Inc.: 1 patents
- Recent patents:
- 20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240711)
- 20240352453. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF RETINOPATHY simplified abstract (Prime Medicine, Inc.) (20241024)
- 20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240523)
Aaron Nakwon CHANG of Lexington MA (US)
- Number of Synthetic Biology patents: 3
- Top companies:
- PRIME MEDICINE, INC.: 3 patents
- Recent patents:
- 20240229038. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240711)
- 20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS simplified abstract (PRIME MEDICINE, INC.) (20240912)
- 20240167026. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF WILSON'S DISEASE simplified abstract (PRIME MEDICINE, INC.) (20240523)
Andrew Vito Anzalone of Cambridge MA (US)
- Number of Synthetic Biology patents: 3
- Top companies:
- The Broad Institute, Inc.: 3 patents
- Recent patents:
- 20240229077. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES simplified abstract (The Broad Institute, Inc.) (20240711)
- 20240158779. METHODS AND COMPOSITIONS FOR SIMULTANEOUS EDITING OF BOTH STRANDS OF A TARGET DOUBLE-STRANDED NUCLEOTIDE SEQUENCE simplified abstract (The Broad Institute, Inc.) (20240516)
- 20240327872. METHODS AND COMPOSITIONS FOR PRIME EDITING NUCLEOTIDE SEQUENCES simplified abstract (The Broad Institute, Inc.) (20241003)
Roman Lvovitch BOGORAD of South Boston MA (US)
- Number of Synthetic Biology patents: 3
- Top companies:
- CRISPR Therapeutics AG: 2 patents
- CRISPR THERAPEUTICS AG: 1 patents
- Recent patents:
- 20240229078. MATERIALS AND METHODS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE TYPE 1A simplified abstract (CRISPR THERAPEUTICS AG) (20240711)
- 20240175014. MATERIALS AND METHODS FOR TREATMENT OF ALPHA-1 ANTITRYPSIN DEFICIENCY simplified abstract (CRISPR Therapeutics AG) (20240530)
- 20240167060. COMPOSITIONS AND METHODS FOR GENOMIC EDITING BY INSERTION OF DONOR POLYNUCLEOTIDES simplified abstract (CRISPR Therapeutics AG) (20240523)
Dewi HARJANTO of Brookline MA (US)
- Number of Synthetic Biology patents: 3
- Top companies:
- Prime Medicine, Inc.: 2 patents
- PRIME MEDICINE, INC.: 1 patents
- Recent patents:
- 20240352453. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF RETINOPATHY simplified abstract (Prime Medicine, Inc.) (20241024)
- 20240301444. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF CYSTIC FIBROSIS simplified abstract (PRIME MEDICINE, INC.) (20240912)
- 20240376466. GENOME EDITING COMPOSITIONS AND METHODS FOR TREATMENT OF FANCONI ANEMIA simplified abstract (Prime Medicine, Inc.) (20241114)
Sofie Aesaert
- Number of Synthetic Biology patents: 3
- Top companies:
- INBIOSE N.V.: 3 patents
- Recent patents:
- 20240368651. CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.) (20241107)
- 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
- 20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES simplified abstract (INBIOSE N.V.) (20241003)
Gert Peters
- Number of Synthetic Biology patents: 3
- Top companies:
- INBIOSE N.V.: 3 patents
- Recent patents:
- 20240368651. CELLULAR PRODUCTION OF DI- AND/OR OLIGOSACCHARIDES simplified abstract (INBIOSE N.V.) (20241107)
- 20240209405. PRODUCTION OF A SIALYLATED OLIGOSACCHARIDE MIXTURE BY A CELL simplified abstract (INBIOSE N.V.) (20240627)
- 20240327888. LACTO-N-BIOSE CONVERTING FUCOSYLTRANSFERASES simplified abstract (INBIOSE N.V.) (20241003)
Jin-Soo Kim
- Number of Synthetic Biology patents: 3
- Top companies:
- TOOLGEN INCORPORATED: 3 patents
- Recent patents:
- 20240052356. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240215)
- 20240240192. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240718)
- 20240026367. Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240125)
Seung Woo Cho
- Number of Synthetic Biology patents: 3
- Top companies:
- TOOLGEN INCORPORATED: 3 patents
- Recent patents:
- 20240052356. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240215)
- 20240240192. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240718)
- 20240026367. Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240125)
Sojung Kim
- Number of Synthetic Biology patents: 3
- Top companies:
- TOOLGEN INCORPORATED: 3 patents
- Recent patents:
- 20240052356. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240215)
- 20240240192. Cas9/RNA Complexes for Inducing Modifications of Target Endogenous Nucleic Acid Sequences in Nucleuses of Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240718)
- 20240026367. Compositions Comprising Cas9/guide RNA Complexes for Inducing Targeted Disruption of Endogenous Genes in Eukaryotic Cells simplified abstract (TOOLGEN INCORPORATED) (20240125)
Krishanu Saha of Madison WI (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- Wisconsin Alumni Research Foundation: 2 patents
- Recent patents:
- 20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation) (20240711)
- 20240131066. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation) (20240425)
Lauren Sarko of Middleton WI (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- Wisconsin Alumni Research Foundation: 2 patents
- Recent patents:
- 20240226152. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation) (20240711)
- 20240131066. SENOLYTIC CRISPR CAR T CELLS PRODUCED BY CRISPR-CAS9 GENOME EDITING simplified abstract (Wisconsin Alumni Research Foundation) (20240425)
Ante Sven Lundberg of Cambridge MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- Vertex Pharmaceuticals Incorporated: 1 patents
- Vertex Phamaceuticals Incorporated: 1 patents
- Recent patents:
Chase Lawrence Beisel of Raleigh NC (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- North Carolina State University: 2 patents
- Recent patents:
Scott Patrick Collins of Raleigh NC (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- North Carolina State University: 2 patents
- Recent patents:
David Baram
- Number of Synthetic Biology patents: 2
- Top companies:
- EmendoBio Inc.: 2 patents
- Recent patents:
Lior Izhar
- Number of Synthetic Biology patents: 2
- Top companies:
- EmendoBio Inc.: 2 patents
- Recent patents:
Rafi Emmanuel
- Number of Synthetic Biology patents: 2
- Top companies:
- EmendoBio Inc.: 2 patents
- Recent patents:
Jonathan M. LEVY of Brookline MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- PRIME MEDICINE, INC.: 2 patents
- Recent patents:
Yuan WANG
- Number of Synthetic Biology patents: 2
- Top companies:
- BEIJING INSTITUTE OF HEART, LUNG AND BLOOD VESSEL DISEASES: 1 patents
- HUAZHONG AGRICULTURAL UNIVERSITY: 1 patents
- Recent patents:
- 20240229045. APTAMER FOR SPECIFICALLY RECOGNIZING SOLUBLE ST2 PROTEIN AND APPLICATION OF THE SAME simplified abstract (BEIJING INSTITUTE OF HEART, LUNG AND BLOOD VESSEL DISEASES) (20240711)
- 20240368675. PAM-LESS ENDONUCLEASE AND GENE EDITING SYSTEM MEDIATED BY PAM-LESS ENDONUCLEASE simplified abstract (HUAZHONG AGRICULTURAL UNIVERSITY) (20241107)
James William Nelson of Cambridge MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- The Broad Institute, Inc.: 2 patents
- Recent patents:
Chad Albert COWAN of South Boston MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- CRISPR THERAPEUTICS AG: 1 patents
- CRISPR Therapeutics AG: 1 patents
- Recent patents:
Ante Sven LUNDBERG of South Boston MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- CRISPR THERAPEUTICS AG: 1 patents
- CRISPR Therapeutics AG: 1 patents
- Recent patents:
Rasmus O. Bak of Stanford CA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- Recent patents:
- 20240124895. NUCLEASE-MEDIATED GENOME EDITING OF PRIMARY CELLS AND RELATED KITS simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20240418)
- 20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20241205)
Ayal Hendel of Stanford CA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- Recent patents:
- 20240124895. NUCLEASE-MEDIATED GENOME EDITING OF PRIMARY CELLS AND RELATED KITS simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20240418)
- 20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20241205)
Matthew H. Porteus of Stanford CA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- Recent patents:
- 20240124895. NUCLEASE-MEDIATED GENOME EDITING OF PRIMARY CELLS AND RELATED KITS simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20240418)
- 20240401034. Chemically Modified Guide RNAs for CRISPR/CAS-Mediated Gene Correction simplified abstract (The Board of Trustees of the Leland Stanford Junior University) (20241205)
Michael Andreas Kock
- Number of Synthetic Biology patents: 2
- Top companies:
- INARI AGRICULTURE TECHNOLOGY, INC.: 2 patents
- Recent patents:
- 20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240905)
- 20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240111)
Michael Lee Nuccio of Salem NH (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- INARI AGRICULTURE TECHNOLOGY, INC.: 2 patents
- Recent patents:
- 20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240905)
- 20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240111)
Frédéric Van Ex
- Number of Synthetic Biology patents: 2
- Top companies:
- INARI AGRICULTURE TECHNOLOGY, INC.: 2 patents
- Recent patents:
- 20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240905)
- 20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240111)
Alexandra Elata of Arlington MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- INARI AGRICULTURE TECHNOLOGY, INC.: 2 patents
- Recent patents:
- 20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240905)
- 20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240111)
Daniel Rodriguez Leal of Raleigh NC (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- INARI AGRICULTURE TECHNOLOGY, INC.: 2 patents
- Recent patents:
- 20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240905)
- 20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240111)
Joshua L. Price of Cambridge MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- INARI AGRICULTURE TECHNOLOGY, INC.: 2 patents
- Recent patents:
- 20240294937. GENOME EDITING OF TRANSGENIC CROP PLANTS WITH MODIFIED TRANSGENIC LOCI simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240905)
- 20240011043. GENERATION OF PLANTS WITH IMPROVED TRANSGENIC LOCI BY GENOME EDITING simplified abstract (INARI AGRICULTURE TECHNOLOGY, INC.) (20240111)
Sofie De Maeseneire
- Number of Synthetic Biology patents: 2
- Top companies:
- INBIOSE N.V.: 2 patents
- Recent patents:
Yatti De Nijs
- Number of Synthetic Biology patents: 2
- Top companies:
- INBIOSE N.V.: 2 patents
- Recent patents:
Tom Delmulle
- Number of Synthetic Biology patents: 2
- Top companies:
- INBIOSE N.V.: 2 patents
- Recent patents:
Yakeel T. Quiroz of Charlestown MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- The General Hospital Corporation: 2 patents
- Recent patents:
Joseph F. Arboleda-Velasquez of Newton MA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- The General Hospital Corporation: 2 patents
- Recent patents:
Eric Reiman of Phoenix AZ (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- The General Hospital Corporation: 2 patents
- Recent patents:
Francisco Lopera
- Number of Synthetic Biology patents: 2
- Top companies:
- The General Hospital Corporation: 2 patents
- Recent patents:
Radwanul Hasan SIDDIQUE of Monrovia CA (US)
- Number of Synthetic Biology patents: 2
- Top companies:
- Samsung Electronics Co., Ltd.: 2 patents
- Recent patents:
Top Collaborations in Synthetic Biology
Top US States for Synthetic Biology Inventors
Top Cities for Synthetic Biology Inventors
- Cambridge: 81 inventors
- Zwijnaarde: 43 inventors
- San Diego: 37 inventors
- Beijing: 18 inventors
- South Boston: 18 inventors
- Boston: 16 inventors
- Seoul: 16 inventors
- Wuhan: 15 inventors
- Stanford: 14 inventors
- Seattle: 14 inventors
- San Francisco: 13 inventors
- Chicago: 10 inventors
- Irvine: 10 inventors
- Durham: 10 inventors
- Raleigh: 8 inventors
- Brookline: 8 inventors
- Burlington: 8 inventors
- Madison: 7 inventors
- Alameda: 7 inventors
- Boise: 7 inventors
